Entrada Therapeutics Inc (TRDA)

Investing Cash Flow

$54.95M

Quarterly · Period ending: · USD

TRDA logo

TRDA Investing Cash Flow

Latest reported$54.95M
TRDA Quarterly Cash from Investing (-$315.00K → $54.95M)
High-resolution chart · PNG

TRDA investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Entrada Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
54,949,000
26,987,000
29,119,000
49,109,000
33,797,000
4,783,000
53,365,000
-82,927,000
-24,383,000
26,147,000
19,043,000
-3,737,000
-113,257,000
-40,444,000
18,792,000
-10,134,000
24,225,000
-181,533,000
-1,322,000
-806,000
-1,544,000
-908,000
-1,451,000
-237,000
-315,000
-315,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.